Lukas Richter
Siemens
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lukas Richter.
Scientific Reports | 2016
Mathias Reisbeck; Michael Johannes Helou; Lukas Richter; Barbara Kappes; Oliver Friedrich; Oliver Hayden
Over the past 50 years, flow cytometry has had a profound impact on preclinical and clinical applications requiring single cell function information for counting, sub-typing and quantification of epitope expression. At the same time, the workflow complexity and high costs of such optical systems still limit flow cytometry applications to specialized laboratories. Here, we present a quantitative magnetic flow cytometer that incorporates in situ magnetophoretic cell focusing for highly accurate and reproducible rolling of the cellular targets over giant magnetoresistance sensing elements. Time-of-flight analysis is used to unveil quantitative single cell information contained in its magnetic fingerprint. Furthermore, we used erythrocytes as a biological model to validate our methodology with respect to precise analysis of the hydrodynamic cell diameter, quantification of binding capacity of immunomagnetic labels, and discrimination of cell morphology. The extracted time-of-flight information should enable point-of-care quantitative flow cytometry in whole blood for clinical applications, such as immunology and primary hemostasis.
Basic & Clinical Pharmacology & Toxicology | 2018
Katharina Netzer; Galateja Jordakieva; Angelika M. Girard; Alexandra C. Budinsky; Alexander Pilger; Lukas Richter; Nadezhda Kataeva; Joerg Schotter; Jasminka Godnic-Cvar; Peter Ertl
Metal nanoparticles (NPs) have unique physicochemical properties and a widespread application scope depending on their composition and surface characteristics. Potential biomedical applications and the growing diversity of novel nanocomposites highlight the need for toxicological hazard assessment of next‐generation magnetic nanomaterials. Our study aimed to evaluate the cytotoxic and genotoxic properties of coated and uncoated ferric cobalt boron (FeCoB) NPs (5–15 nm particle size) in cultured normal human dermal fibroblasts. Cell proliferation was assessed via ATP bioluminescence kit, and DNA breakage and chromosomal damage were measured by alkaline comet assay and micronucleus test. Polyacryl acid‐coated FeCoB NPs [polyacrylic acid (PAA)‐FeCoB NPs) and uncoated FeCoB NPs inhibited cell proliferation at 10 μg/ml. DNA strand breaks were significantly increased by PAA‐coated FeCoB NPs, uncoated FeCoB NPs and l‐cysteine‐coated FeCoB NPs (Cys‐FeCoB NPs), although high concentrations (10 μg/ml) of coated NPs (Cys‐ and PAA‐FeCoB NPs) showed significantly more DNA breakage when compared to uncoated ones. Uncoated FeCoB NPs and coated NPs (PAA‐FeCoB NPs) also induced the formation of micronuclei. Additionally, PAA‐coated NPs and uncoated FeCoB NPs showed a negative correlation between cell proliferation and DNA strand breaks, suggesting a common pathomechanism, possibly by oxidation‐induced DNA damage. We conclude that uncoated FeCoB NPs are cytotoxic and genotoxic at in vitro conditions. Surface coating of FeCoB NPs with Cys and PAA does not prevent but rather aggravates DNA damage. Further safety assessment and a well‐considered choice of surface coating are needed prior to application of FeCoB nanocomposites in biomedicine.
Biosensors and Bioelectronics | 2018
Mathias Reisbeck; Lukas Richter; Michael Johannes Helou; Stephan Arlinghaus; Birgit Anton; Ignas van Dommelen; Mario Nitzsche; Michael Baßler; Barbara Kappes; Oliver Friedrich; Oliver Hayden
Time-of-flight (TOF) magnetic sensing of rolling immunomagnetically-labeled cells offers great potential for single cell function analysis at the bedside in even optically opaque media, such as whole blood. However, due to the spatial resolution of the sensor and the low flow rate regime required to observe the behavior of rolling cells, the concentration range of such a workflow is limited. Potential clinical applications, such as testing of leukocyte function, require a cytometer which can cover a cell concentration range of several orders of magnitude. This is a challenging task for an integrated dilution-free workflow, as for high cell concentrations coincidences need to be avoided, while for low cell concentrations sufficient statistics should be provided in a reasonable time-to-result. Here, we extend the spatial bandwidth of a magnetoresistive sensor with an adaptive and integratable workflow concept combining mechanical and magnetophoretic guiding of magnetically labeled targets for in-situ enrichment over a dynamic concentration range of 3 orders of magnitude. We achieve hybrid integration of the enrichment strategy in a cartridge mold and a giant-magnetoresistance (GMR) sensor in a functionalized Quad Flat No-Lead (QFN) package, which allows for miniaturization of the Si footprint for potential low-cost bedside testing. The enrichment results demonstrate that TOF magnetic flow cytometry with adaptive particle focusing can match the clinical requirements for a point-of-care (POC) cytometer and can potentially be of interest for other sheath-less methodologies requiring workflow integration.
Advanced Science | 2018
Matthias Ugele; Markus Weniger; Manfred Stanzel; Michael Bassler; Stefan W. Krause; Oliver Friedrich; Oliver Hayden; Lukas Richter
Complete blood count and differentiation of leukocytes (DIFF) belong to the most frequently performed laboratory diagnostic tests. Here, a flow cytometry-based method for label-free DIFF of untouched leukocytes by digital holographic microscopy on the rich phase contrast of peripheral leukocyte images, using highly controlled 2D hydrodynamic focusing conditions is reported. Principal component analysis of morphological characteristics of the reconstructed images allows classification of nine leukocyte types, in addition to different types of leukemia and demonstrates disappearance of acute myeloid leukemia cells in remission. To exclude confounding effects, the classification strategy is tested by the analysis of 20 blinded clinical samples. Here, 70% of the specimens are correctly classified with further 20% classifications close to a correct diagnosis. Taken together, the findings indicate a broad clinical applicability of the cytometry method for automated and reagent-free diagnosis of hematological disorders.
Lab on a Chip | 2013
Michael Johannes Helou; Mathias Reisbeck; Sandro Francesco Tedde; Lukas Richter; Ludwig Bär; Jacobus J. Bosch; Roland H. Stauber; Eckhard Quandt; Oliver Hayden
Archive | 2014
Oliver Hayden; Michael Johannes Helou; Mathias Reisbeck; Lukas Richter
Archive | 2014
Oliver Hayden; Lukas Richter; Manfred Rührig; Oliver Schmidt
Lab on a Chip | 2018
Matthias Ugele; Markus Weniger; Maria Leidenberger; Yiwei Huang; Michael Bassler; Oliver Friedrich; Barbara Kappes; Oliver Hayden; Lukas Richter
Archive | 2017
Oliver Hayden; Lukas Richter; Oliver Schmidt; Sandro Francesco Tedde
Archive | 2015
Tobias Endner; Oliver Hayden; Michael Johannes Helou; Benjamin Krafft; Lukas Richter; Andreas Wiemhöfer